NCT03744949View on ClinicalTrials.gov

ED50 and ED95 of Remifentanil for Intubation Without NOL Variation

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

October 19, 2018

Study Completion Date

September 30, 2021

Conditions
Intubation; Difficult or Failed
Interventions
DRUG

Remifentanil dose 0.5 ug/kg

Remifentanil will be given (dosage of 0.5 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds

DRUG

Remifentanil dose 1 ug/kg

Remifentanil will be given (dosage of 1 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds

DRUG

Remifentanil dose 1.5 ug/kg

Remifentanil will be given (dosage of 1.5 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds

DRUG

Remifentanil dose 2 ug/kg

Remifentanil will be given (dosage of 2 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds

Trial Locations (1)

H1T2M4

Hopital Maisonneuve Rosemont, Montreal East

All Listed Sponsors
lead

Ciusss de L'Est de l'Île de Montréal

OTHER

NCT03744949 - ED50 and ED95 of Remifentanil for Intubation Without NOL Variation | Biotech Hunter | Biotech Hunter